vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and MFA FINANCIAL, INC. (MFA). Click either name above to swap in a different company.

MFA FINANCIAL, INC. is the larger business by last-quarter revenue ($55.5M vs $38.9M, roughly 1.4× CODEXIS, INC.). On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 9.2%). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 7.7%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

MFA Financial, Inc. is a U.S.-headquartered real estate investment trust (REIT) specializing in investing in and managing residential and commercial mortgage-backed securities, mortgage loans, and other real estate-related financial assets. It caters primarily to institutional and individual investors across the U.S., focusing on delivering stable risk-adjusted returns via rigorous asset screening and risk management frameworks.

CDXS vs MFA — Head-to-Head

Bigger by revenue
MFA
MFA
1.4× larger
MFA
$55.5M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+72.1% gap
CDXS
81.3%
9.2%
MFA
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
7.7%
MFA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
MFA
MFA
Revenue
$38.9M
$55.5M
Net Profit
$9.6M
Gross Margin
94.8%
Operating Margin
27.1%
97.9%
Net Margin
24.7%
Revenue YoY
81.3%
9.2%
Net Profit YoY
192.5%
EPS (diluted)
$0.13
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
MFA
MFA
Q4 25
$38.9M
$55.5M
Q3 25
$8.6M
$56.8M
Q2 25
$15.3M
$61.3M
Q1 25
$7.5M
$57.5M
Q4 24
$21.5M
$50.8M
Q3 24
$12.8M
$50.6M
Q2 24
$8.0M
$53.5M
Q1 24
$17.1M
$47.8M
Net Profit
CDXS
CDXS
MFA
MFA
Q4 25
$9.6M
Q3 25
$-19.6M
$48.1M
Q2 25
$-13.3M
$33.2M
Q1 25
$-20.7M
$41.2M
Q4 24
$-10.4M
Q3 24
$-20.6M
$48.2M
Q2 24
$-22.8M
$41.9M
Q1 24
$-11.5M
$23.2M
Gross Margin
CDXS
CDXS
MFA
MFA
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
MFA
MFA
Q4 25
27.1%
97.9%
Q3 25
-220.3%
84.5%
Q2 25
-83.9%
54.5%
Q1 25
-271.6%
70.0%
Q4 24
-34.2%
6.8%
Q3 24
-129.0%
98.2%
Q2 24
-284.9%
79.1%
Q1 24
-69.6%
50.7%
Net Margin
CDXS
CDXS
MFA
MFA
Q4 25
24.7%
Q3 25
-228.1%
84.7%
Q2 25
-86.6%
54.2%
Q1 25
-274.3%
71.6%
Q4 24
-48.4%
Q3 24
-160.8%
95.2%
Q2 24
-285.2%
78.4%
Q1 24
-67.4%
48.5%
EPS (diluted)
CDXS
CDXS
MFA
MFA
Q4 25
$0.13
$0.43
Q3 25
$-0.22
$0.35
Q2 25
$-0.16
$0.21
Q1 25
$-0.25
$0.31
Q4 24
$-0.12
$-0.01
Q3 24
$-0.29
$0.37
Q2 24
$-0.32
$0.32
Q1 24
$-0.16
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
MFA
MFA
Cash + ST InvestmentsLiquidity on hand
$78.2M
$213.2M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$1.8B
Total Assets
$147.8M
$13.0B
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
MFA
MFA
Q4 25
$78.2M
$213.2M
Q3 25
$58.7M
$305.2M
Q2 25
$66.3M
$275.7M
Q1 25
$59.8M
$253.7M
Q4 24
$73.5M
$338.9M
Q3 24
$90.3M
$305.6M
Q2 24
$73.2M
$289.4M
Q1 24
$85.5M
$306.3M
Total Debt
CDXS
CDXS
MFA
MFA
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
MFA
MFA
Q4 25
$50.5M
$1.8B
Q3 25
$38.5M
$1.8B
Q2 25
$55.6M
$1.8B
Q1 25
$49.6M
$1.8B
Q4 24
$66.9M
$1.8B
Q3 24
$73.4M
$1.9B
Q2 24
$61.4M
$1.9B
Q1 24
$79.3M
$1.9B
Total Assets
CDXS
CDXS
MFA
MFA
Q4 25
$147.8M
$13.0B
Q3 25
$124.0M
$12.1B
Q2 25
$138.2M
$11.7B
Q1 25
$128.9M
$11.5B
Q4 24
$149.0M
$11.4B
Q3 24
$148.2M
$11.2B
Q2 24
$132.0M
$11.1B
Q1 24
$149.6M
$10.9B
Debt / Equity
CDXS
CDXS
MFA
MFA
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
MFA
MFA
Operating Cash FlowLast quarter
$20.1M
$76.2M
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
MFA
MFA
Q4 25
$20.1M
$76.2M
Q3 25
$-7.7M
$14.7M
Q2 25
$-18.0M
$38.5M
Q1 25
$-13.8M
$-14.6M
Q4 24
$-16.5M
$200.1M
Q3 24
$-13.0M
$-11.3M
Q2 24
$-12.2M
$46.5M
Q1 24
$-7.8M
$53.5M
Free Cash Flow
CDXS
CDXS
MFA
MFA
Q4 25
$19.6M
Q3 25
$-7.9M
Q2 25
$-20.5M
Q1 25
$-15.1M
Q4 24
$-18.2M
Q3 24
$-14.0M
Q2 24
$-12.6M
Q1 24
$-8.9M
FCF Margin
CDXS
CDXS
MFA
MFA
Q4 25
50.3%
Q3 25
-91.7%
Q2 25
-133.6%
Q1 25
-199.6%
Q4 24
-85.0%
Q3 24
-109.0%
Q2 24
-157.5%
Q1 24
-52.2%
Capex Intensity
CDXS
CDXS
MFA
MFA
Q4 25
1.3%
Q3 25
2.1%
Q2 25
16.4%
Q1 25
16.7%
Q4 24
8.3%
Q3 24
7.8%
Q2 24
5.0%
Q1 24
6.6%
Cash Conversion
CDXS
CDXS
MFA
MFA
Q4 25
2.09×
Q3 25
0.31×
Q2 25
1.16×
Q1 25
-0.35×
Q4 24
Q3 24
-0.23×
Q2 24
1.11×
Q1 24
2.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons